CalciTech Appoints MD for European Operations
CalciTech Ltd. (OTCBB: CLK) announces today the appointment of Michael Watts as Managing Director of CalciTech Synthetic Minerals Europe Limited (“CSME”), its UK based wholly-owned European operating subsidiary. The acting Managing Director, Michael Brickell, will now become a non-executive director.
CSME has an independent UK board of directors and senior management with extensive commercial, industrial and financial experience, and will operate independently within Europe.
CSME will be responsible for building the first SCC production plants in Europe and making product available to the market.
Mr. Watts has a strong track record in bringing new technologies to commercialisation. Previously on the Boards of Alpine Venture Partners and BTG S.A., both of Switzerland, he most recently spent 6 years as President and CEO of the BTG Group, a multinational company owned by Spectris plc with €100 million in sales and 450 employees. BTG provides instrumentation and consumable products to the pulp and paper industry. While at BTG, he led the Company's development into becoming a highly profitable operation despite adverse market conditions.
Prior to BTG, Mr. Watts held several senior positions with various companies such as President of Beta Lasermike Inc. (a Spectris company), Raychem Corporation of Menlo Park California (now Tyco Electronics), and Beecham Pharmaceuticals (now GlaxoSmithKline). A physicist by training, Mr. Watts holds an MBA from INSEAD.
Roger Leopard, CEO of CalciTech Limited said: “I’m delighted that Michael Watts has joined CSME at this time as his ability, experience and knowledge will drive the implementation of CSME’s business plan.”
